Lupiher2 Injection is a targeted cancer medicine that contains pertuzumab and trastuzumab, two monoclonal antibodies used together to treat HER2‑positive breast cancer. HER2‑positive cancer cells have high levels of the human epidermal growth factor receptor 2 protein, which drives tumour growth. This combination blocks the HER2 receptors on cancer cells, stopping them from receiving growth signals and helping slow or stop cancer progression. It is used in adults with HER2‑positive breast cancer that has spread to other parts of the body, is at high risk of recurrence, or is being treated before or after surgery as part of a comprehensive cancer treatment plan. Your doctor will explain why it is suitable for you.

Lupiher2 Injection is given by a healthcare professional as an intravenous infusion into a vein, typically in a clinic or hospital setting. It should not be self‑administered. Your doctor will decide the correct dose and treatment schedule based on your specific condition and response to treatment.

Side effects can occur with pertuzumab and trastuzumab therapy. Common side effects may include diarrhoea, nausea, hair loss, fatigue, rash, infusion‑related reactions and decreased blood cell counts. More serious side effects can include heart problems, severe allergic reactions and pulmonary toxicity. Contact your doctor immediately if you notice severe or unusual symptoms.

You can obtain Lupiher2 Injection from licensed pharmacies and oncology supply centres with a valid prescription. Contact Macarius Health to check availability and pricing.

Store Lupiher2 Injection in a refrigerator at 2°C to 8°C and do not freeze. Protect from light and keep the medicine in its original packaging out of reach of children and pets.

Tell your doctor about all other medicines, supplements or herbal products you are taking. Some medicines may interact with targeted cancer therapies or affect how they work, which could influence effectiveness or increase the risk of side effects. Your doctor may adjust your treatment or monitoring accordingly.

Lupiher2 Injection is not recommended during pregnancy or while breastfeeding unless clearly advised by your doctor. Medications that target HER2 can harm a developing fetus or nursing infant. Discuss any concerns with your healthcare provider before starting treatment.

Delivery time depends on stock availability and location. Macarius Health arranges prompt delivery within Delhi NCR. For other cities across India, delivery typically follows standard courier timelines.